Prenetics
PublicPrenetics is now publicly traded
The data on this page reflects Prenetics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Growth Equity
Jul 14, 2026
Total Funding Raised
$1B
Company Overview
Prenetics is a health sciences company that specializes in consumer and clinical health solutions, including multi-cancer early detection technologies, advanced genomic profiling, and wellness products.
Sector
Healthcare/Wellness
AI Layer
Application
Keywords
Prenetics Comparables
Compare Prenetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Agen Genomics, Inc. | 56% |
Prenetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jul 14, 2026 |
Key People
Founding team and executive leadership
Prenetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| General Catalyst's Customer Value Fund | Growth Equity |
Prenetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access